| Daylied Espinal, LMHC | |
|
8454 Nw 27th St, Pembroke Pines, FL 33024-5286 | |
| (954) 769-0906 | |
| Not Available |
| Full Name | Daylied Espinal |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 8454 Nw 27th St, Pembroke Pines, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053027284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | MH21843 (Florida) | Primary |
| Entity Name | Grow Healthcare Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245845932 PECOS PAC ID: 3476961368 Enrollment ID: O20210414000053 |
News Archive
Insulin uses two distinct mechanisms to control glucose and the metabolism of blood fats (lipids) in the liver, a new Joslin Diabetes Center-led study has discovered.
The fixed-ratio combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since September 2014 for adults with type 2 diabetes mellitus. It is given as an injection in addition to other blood-glucose lowering drugs when these alone or in combination with basal insulin are insufficient to lower blood glucose levels.
On Nov. 21, 2016, the American Society of Gene & Cell Therapy released Therapeutic Gene Editing: an ASGCT White Paper, intended to provide policy-makers, patient advocates, and the interested public with the necessary background information in anticipation of an upcoming consensus report on human gene editing from the National Academy of Sciences and National Academy of Medicine (NAS), expected to be released in early 2017.
Hitachi High-Technologies Corporation and QIAGEN N.V. have entered into a long-term strategic collaboration involving initiatives to deliver important advances in molecular testing.
Silverlink Communications® Inc., the leader in healthcare consumer communications, today announced solutions focused specifically on the Medicare market. These services help health plans more effectively communicate with beneficiaries, especially important in the 2010 plan year open enrollment season starting in October 2009.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daylied Espinal, LMHC 8454 Nw 27th St, Pembroke Pines, FL 33024-5286 Ph: () - | Daylied Espinal, LMHC 8454 Nw 27th St, Pembroke Pines, FL 33024-5286 Ph: (954) 769-0906 |
News Archive
Insulin uses two distinct mechanisms to control glucose and the metabolism of blood fats (lipids) in the liver, a new Joslin Diabetes Center-led study has discovered.
The fixed-ratio combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since September 2014 for adults with type 2 diabetes mellitus. It is given as an injection in addition to other blood-glucose lowering drugs when these alone or in combination with basal insulin are insufficient to lower blood glucose levels.
On Nov. 21, 2016, the American Society of Gene & Cell Therapy released Therapeutic Gene Editing: an ASGCT White Paper, intended to provide policy-makers, patient advocates, and the interested public with the necessary background information in anticipation of an upcoming consensus report on human gene editing from the National Academy of Sciences and National Academy of Medicine (NAS), expected to be released in early 2017.
Hitachi High-Technologies Corporation and QIAGEN N.V. have entered into a long-term strategic collaboration involving initiatives to deliver important advances in molecular testing.
Silverlink Communications® Inc., the leader in healthcare consumer communications, today announced solutions focused specifically on the Medicare market. These services help health plans more effectively communicate with beneficiaries, especially important in the 2010 plan year open enrollment season starting in October 2009.
› Verified 8 days ago
Ms. Susi Blitman, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2010 Nw 150th Ave, Pembroke Pines, FL 33028 Phone: 954-431-9838 Fax: 954-779-2316 | |
Denise Brown, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1000 N Hiatus Rd Ste 140161, Pembroke Pines, FL 33026 Phone: 954-333-8787 | |
Vanessa Matute, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1000 N Hiatus Rd, Pembroke Pines, FL 33026 Phone: 954-333-8787 | |
Dontraey Oliver-johnson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1152 N University Dr, Pembroke Pines, FL 33024 Phone: 954-639-7345 | |
Dr. Eugenio Figueroa, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 1984 Nw 179th Ave, Pembroke Pines, FL 33029 Phone: 305-333-0910 | |
Raychelle Fraser, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1152 N University Dr, Pembroke Pines, FL 33024 Phone: 195-463-9734 | |
Mrs. Judith Roberts, L.M.H.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 10031 Pines Blvd, Suite 248, Pembroke Pines, FL 33024 Phone: 305-308-6145 Fax: 954-392-9958 |